BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19621005)

  • 1. Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet...
    Nakazawa G; Ladich E; Virmani R
    Clin Pharmacol Ther; 2009 Aug; 86(2):127-30. PubMed ID: 19621005
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of drug-eluting stents.
    Windecker S; Jüni P
    Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):316-28. PubMed ID: 18414453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do the benefits outweigh the risks with drug-eluting stents?
    Kløw NE
    Scand Cardiovasc J; 2007 Jan; 41(1):8-9. PubMed ID: 17365970
    [No Abstract]   [Full Text] [Related]  

  • 5. Late stent thrombosis in drug-eluting stents: return of the 'VB syndrome'.
    Serruys PW; Kukreja N
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):637. PubMed ID: 17122790
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-eluting stent thrombosis: it's never too late.
    Kandzari DE
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):638-9. PubMed ID: 17122791
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular medicine: a look forward.
    Holstein SA; Hohl RJ
    Clin Pharmacol Ther; 2009 Aug; 86(2):117-9. PubMed ID: 19621001
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
    Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
    Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significantly lower incidence of early definite stent thrombosis of drug-eluting stents after unrestricted use in Japan using ticlopidine compared to western countries using clopidogrel: a retrospective comparison with western mega-studies.
    Ishikawa T; Nakano Y; Endoh A; Kubota T; Suzuki T; Nakata K; Miyamoto T; Murakami M; Sakamoto H; Imai K; Mochizuki S; Yoshimura M; Mutoh M
    J Cardiol; 2009 Oct; 54(2):238-44. PubMed ID: 19782261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stents are safe.
    Garg S; Serruys P
    Clin Pharmacol Ther; 2009 Aug; 86(2):130-2. PubMed ID: 19621006
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stent pathology--should we still be cautious?
    Nakazawa G; Finn AV; Virmani R
    Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):1. PubMed ID: 18094669
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
    Ayyanathan S; Hersh D; Coplan NL; Garratt K
    Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards defining the role of drug eluting stents.
    Tarantini G; Ramondo A; Razzolini R
    Minerva Cardioangiol; 2008 Feb; 56(1):29-34. PubMed ID: 18432166
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary stents, hypersensitivity reactions, and the Kounis syndrome.
    Kounis NG; Hahalis G; Theoharides TC
    J Interv Cardiol; 2007 Oct; 20(5):314-23. PubMed ID: 17880327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SES for AMI: moving in the right direction.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):333-4. PubMed ID: 19642181
    [No Abstract]   [Full Text] [Related]  

  • 18. A critical appraisal of the safety and efficacy of drug-eluting stents.
    Maluenda G; Lemesle G; Waksman R
    Clin Pharmacol Ther; 2009 May; 85(5):474-80. PubMed ID: 19279567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The editor's roundtable: bare-metal stents versus drug-eluting stents-indications and complications.
    Friedewald VE; Kastrati A; Roberts WC; Vetrovec GW; Windecker S
    Am J Cardiol; 2008 Jul; 102(1):32-9. PubMed ID: 18572032
    [No Abstract]   [Full Text] [Related]  

  • 20. Sorting out drug-eluting stents.
    Webster MW; Ormiston JA
    Lancet; 2010 Mar; 375(9720):1060-2. PubMed ID: 20231035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.